/term/bs-money-market/TSX:ASP Acerus Pharmaceuticals (TSX:ASP) Money Market Investments
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Money Market Investments

Acerus Pharmaceuticals (TSX:ASP) Money Market Investments


View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Money Market Investments?

Money Market Investments only applies to banks.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Money Market Investments
Comparable Companies
TSXV:NDVA TSX:AH XCNQ:LOWL TSX:NEPT XCNQ:VEXT TSX:WLLW TSXV:KHRN TSX:DN TSXV:DB XCNQ:TRIP XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8
Website
https://www.aceruspharma.com
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Executives
Norma Beauchamp Director
Stephen Robert Gregory Director
Edward Joseph Gudaitis Director, Senior Officer